Three stacked medical reference books of increasing thickness on a clinic desk beside a stethoscope and a closed laptop

Obesity Classes I, II and III Explained

5 min read

By Longevity Lab · Published: August 23, 2026

Based on peer-reviewed research — full source list at the end of this article. This is educational information, not medical advice.


Key takeaways
  • Class I is BMI 30.0–34.9, class II is 35.0–39.9, class III is 40.0 and above.
  • The classes decide eligibility for structured weight management, GLP-1 medication and bariatric surgery in most health systems.
  • Thresholds drop by roughly 2.5 units when a weight-related condition is already present, and for people of Asian descent.
  • A 2025 Lancet Commission proposed separating clinical from preclinical obesity, because BMI alone cannot tell them apart.
  • The class describes body size. It says nothing about whether organs are affected.

Obesity is divided into three classes — class I at BMI 30.0–34.9, class II at 35.0–39.9 and class III at 40.0 and above — because the risks and the treatment options change materially between them rather than gradually across them. The boundaries are administrative as much as biological: they determine what care a health system offers. What they do not determine is whether a given person is actually unwell, which is the distinction a 2025 Lancet Commission set out to fix.

The three classes and what attaches to each

ClassBMIWeight at 1.75 mTypically associated with
Class I30.0–34.991.9–106.9 kgType 2 diabetes, hypertension, dyslipidemia, fatty liver
Class II35.0–39.9107.2–122.2 kgThe above plus sleep apnea, knee and hip osteoarthritis, heart failure
Class III40.0 and above122.5 kg and aboveThe above plus the largest reductions in life expectancy and mobility

Class III is sometimes still called morbid obesity in older literature and in some insurance documents. The term is being retired in clinical writing because it describes the person rather than the condition, but you will still encounter it.

Risk does not step at each boundary — it rises continuously. The classes exist because decisions have to be discrete: a treatment is either offered or it is not.

What the classes unlock clinically

In most health systems the numbers map onto care pathways roughly like this. Class I with no complications: structured lifestyle intervention. Class I with a weight-related condition, or class II: pharmacotherapy becomes appropriate. Class II with a condition, or class III: bariatric surgery enters the conversation.

GLP-1 receptor agonists follow the same logic. The licensed threshold in most jurisdictions is a BMI of 30 and above, or 27 and above with at least one weight-related comorbidity such as type 2 diabetes, hypertension or obstructive sleep apnea. The 27 figure is the reason the comorbidity question is asked before the weight question.

Screening intensity scales the same way. At class I and above, checking for Metabolic syndrome is routine rather than optional, and Metabolic syndrome — the hidden pandemic of the 21st century scores its five criteria — waist, triglycerides, HDL, blood pressure and fasting glucose — as a set. Three of the five is the diagnostic threshold, and it is entirely possible to meet it at class I and not at class II.

Where the thresholds move

The 30/35/40 figures are not universal. Two adjustments are widely applied.

Asian populations. WHO describes 23 as the point of increased risk and 27.5 as high risk for adults of South, South-East and East Asian descent, because visceral fat accumulates and insulin resistance appears at a lower body mass. Several national guidelines set the obesity threshold at 27.5 rather than 30 on that basis.

Existing comorbidity. When a weight-related condition is already present, most treatment thresholds drop by roughly 2.5 BMI units — the reasoning being that the risk the threshold is meant to identify has already materialized.

Both adjustments point at the same weakness: the class is a proxy for risk, and whenever better information about risk exists, the class gives way to it.

Clinical versus preclinical obesity

In 2025 a Lancet Commission of 58 experts proposed replacing BMI-only classification with a two-part definition. Clinical obesity is excess adiposity that is already causing organ dysfunction or limiting daily activities — a disease in its own right. Preclinical obesity is excess adiposity with preserved organ function — a risk factor, not a disease.

The practical consequence is that class and diagnosis come apart. Two people at BMI 33 can be in different categories: one with normal blood pressure, normal glucose, normal liver enzymes and no functional limitation, and one with all four disturbed. The first has a risk factor. The second has a condition. BMI reports 33 for both.

The Commission also recommended that BMI never be used alone for diagnosis — confirming excess adiposity with at least one direct measure, usually waist circumference, waist-to-height ratio or a body-composition measurement. Abdominal obesity is what most of these confirmations are actually looking for.

How to read your own class

If your BMI puts you in a class, the number itself is the least informative part of the finding. Three things determine what it means:

  1. Your waist. At the same class, a smaller waist means a substantially better risk profile.
  2. Your blood panel. Fasting glucose, HbA1c, triglycerides, HDL, liver enzymes and blood pressure decide whether this is preclinical or clinical.
  3. Your function. Breathlessness on stairs, joint pain, disturbed sleep — these are what the classification is ultimately a proxy for.

Run our BMI calculator to place the number, then take the other measurements. The Body Mass Index (BMI) tool reports the class alongside a mortality-risk ratio, which is a more honest presentation than a category name that sounds like a diagnosis but is not one.

Frequently asked questions

What BMI is class 3 obesity?

40.0 and above. It was previously called morbid obesity, a term being retired in clinical writing because it labels the person rather than the condition.

What is the difference between obesity class 1 and 2?

Class I is BMI 30.0–34.9 and class II is 35.0–39.9. The boundary matters mainly because treatment eligibility, especially for surgery, changes across it.

Can you be in an obesity class and metabolically healthy?

Yes, at least for a period. The 2025 Lancet Commission calls this preclinical obesity — excess adiposity with preserved organ function. It still carries elevated future risk.

Do obesity thresholds differ by ethnicity?

Yes. WHO describes 23 as increased risk and 27.5 as high risk for adults of South, South-East and East Asian descent, and several national guidelines follow those figures.

Sources

Sources (4)
  1. Rubino F, Cummings DE, Eckel RH, et al. Definition and diagnostic criteria of clinical obesity. Lancet Diabetes Endocrinol. 2025;13:221–262. PubMed →
  2. WHO Expert Consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–163. PubMed →
  3. Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement. Circulation. 2009;120:1640–1645. PubMed →
  4. Yumuk V, Tsigos C, Fried M, et al. European guidelines for obesity management in adults. Obes Facts. 2015;8:402–424. PubMed →

Disclaimer. This article is for information only and does not replace medical advice. Talk to a qualified clinician before changing anything about your health.

Similar Posts